US4115577A
(en)
*
|
1972-06-19 |
1978-09-19 |
Endo Laboratories, Inc. |
Pyridopyrrolobenzheterocycles
|
US4183936A
(en)
*
|
1972-06-19 |
1980-01-15 |
Endo Laboratories, Inc. |
Pyridopyrrolobenzheterocycles
|
US4013652A
(en)
*
|
1972-06-19 |
1977-03-22 |
Endo Laboratories, Inc. |
Pyridopyrrolobenzoxazine
|
GB2022093B
(en)
*
|
1978-06-05 |
1982-09-15 |
Sankyo Co |
Benzothalzocines and benzothiazonines
|
US4219550A
(en)
*
|
1978-11-09 |
1980-08-26 |
E. I. Du Pont De Nemours And Company |
Cis- and trans- octahydropyridopyrrolobenzheterocycles
|
JPH02180885A
(ja)
*
|
1988-09-01 |
1990-07-13 |
Glaxo Group Ltd |
ラクタム誘導体
|
US5223625A
(en)
*
|
1988-12-22 |
1993-06-29 |
Duphar International Research B.V. |
Annelated indolo [3,2,-C]lactams
|
EP0380155A1
(en)
*
|
1989-01-19 |
1990-08-01 |
Duphar International Research B.V |
8,9-Annelated-1,2,3,4-tetrahydro-beta-carboline derivatives
|
US7071186B2
(en)
|
1999-06-15 |
2006-07-04 |
Bristol-Myers Squibb Pharma Co. |
Substituted heterocycle fused gamma-carbolines
|
US6552017B1
(en)
|
1999-06-15 |
2003-04-22 |
Bristol-Myers Squibb Pharma Company |
Substituted heterocycle fused gamma-carbolines
|
US6713471B1
(en)
*
|
1999-06-15 |
2004-03-30 |
Bristol-Myers Squibb Pharma Company |
Substituted heterocycle fused gamma-carbolines
|
MXPA03005438A
(es)
*
|
2000-12-20 |
2004-05-05 |
Bristol Myers Squibb Co |
Pirioindoles substituidos como agonistas y antagonistas de serotonina.
|
DE60139511D1
(de)
|
2000-12-20 |
2009-09-17 |
Bristol Myers Squibb Co |
Substituierte pyrrolochinoline und pyridochinoline als serotonin- agonisten und- antagonisten
|
US6849619B2
(en)
*
|
2000-12-20 |
2005-02-01 |
Bristol-Myers Squibb Company |
Substituted pyridoindoles as serotonin agonists and antagonists
|
HUP0303513A3
(en)
|
2000-12-20 |
2005-12-28 |
Bristol Myers Squibb Pharma Co |
Substituted pyrazinoquinoxaline derivatives as serotonin receptor agonists and antagonists, their use and pharmaceutical compositions containing them
|
AU2002336749A1
(en)
*
|
2001-09-21 |
2003-04-01 |
Pharmacia And Upjohn Company |
Tricyclic indole derivatives as 5-ht ligands
|
AU2003303210A1
(en)
*
|
2002-12-19 |
2004-07-14 |
Bristol-Myers Squibb Company |
Substituted tricyclic gamma-carbolines as serotonin receptor agonists and antagonists
|
JP5567349B2
(ja)
|
2007-03-12 |
2014-08-06 |
イントラ−セルラー・セラピーズ・インコーポレイテッド |
置換ヘテロ環縮合ガンマ−カルボリンの合成
|
US8575186B2
(en)
|
2009-10-05 |
2013-11-05 |
Albany Molecular Research, Inc. |
Epiminocycloalkyl[b] indole derivatives as serotonin sub-type 6 (5-HT6) modulators and uses thereof
|
US9067949B2
(en)
|
2011-01-19 |
2015-06-30 |
Albany Molecular Research, Inc. |
Benzofuro[3,2-c] pyridines and related analogs as serotonin sub-type 6 (5-HT6) modulators for the treatment of obesity, metabolic syndrome, cognition and schizophrenia
|
ES2727815T3
(es)
|
2012-04-14 |
2019-10-18 |
Intra Cellular Therapies Inc |
Tratamiento del TEPT y de trastornos del control de impulsos
|
EP2968320B1
(en)
|
2013-03-15 |
2020-11-11 |
Intra-Cellular Therapies, Inc. |
Organic compounds
|
KR102495941B1
(ko)
|
2013-12-03 |
2023-02-06 |
인트라-셀룰라 써래피스, 인코퍼레이티드. |
신규한 방법
|
MX2016013046A
(es)
|
2014-04-04 |
2017-02-15 |
Intra-Cellular Therapies Inc |
Compuestos organicos.
|
BR112016023162B1
(pt)
|
2014-04-04 |
2022-11-29 |
Intra-Cellular Therapies, Inc |
Compostos orgânicos gama-carbolinas, composições farmacêuticas compreendendo os ditos compostos e uso dos mesmos no tratamento ou na profilaxia de transtornos de sistema nervoso central
|
BR112018015283B1
(pt)
|
2016-01-26 |
2023-09-26 |
Intra-Cellular Therapies, Inc |
Compostos orgânicos, composição farmacêutica compreendendo os ditos compostos e uso dos mesmos para o tratamento ou profilaxia de um distúrbio do sistema nervoso central
|
EP3888656A1
(en)
|
2016-03-25 |
2021-10-06 |
Intra-Cellular Therapies, Inc. |
Deuterated heterocyclic gamma-carboline compounds and their use in the treatment or prophylaxis of a central nervous system disorder
|
EP3436016B1
(en)
|
2016-03-28 |
2022-04-27 |
Intra-Cellular Therapies, Inc. |
Novel co-crystals
|
WO2017172795A1
(en)
|
2016-03-28 |
2017-10-05 |
Intra-Cellular Therapies, Inc. |
Novel compositions and methods
|
EP3436455A4
(en)
|
2016-03-28 |
2019-09-04 |
Intra-Cellular Therapies, Inc. |
NOVEL SALTS AND CRYSTALS
|
US11331316B2
(en)
|
2016-10-12 |
2022-05-17 |
Intra-Cellular Therapies, Inc. |
Amorphous solid dispersions
|
US10961245B2
(en)
|
2016-12-29 |
2021-03-30 |
Intra-Cellular Therapies, Inc. |
Substituted heterocycle fused gamma-carbolines for treatment of central nervous system disorders
|
WO2018126143A1
(en)
|
2016-12-29 |
2018-07-05 |
Intra-Cellular Therapies, Inc. |
Organic compounds
|
CA3054841A1
(en)
|
2017-03-24 |
2018-09-27 |
Intra-Cellular Therapies, Inc. |
Novel compositions and methods
|
WO2019023063A1
(en)
|
2017-07-26 |
2019-01-31 |
Intra-Cellular Therapies, Inc. |
ORGANIC COMPOUNDS
|
MX2020000968A
(es)
|
2017-07-26 |
2020-09-28 |
Intra Cellular Therapies Inc |
Compuestos organicos.
|
JP7483671B2
(ja)
|
2018-06-11 |
2024-05-15 |
イントラ-セルラー・セラピーズ・インコーポレイテッド |
置換ヘテロ環縮合ガンマ-カルボリン類合成
|
EP3843738A4
(en)
|
2018-08-31 |
2022-06-01 |
Intra-Cellular Therapies, Inc. |
NEW METHODS
|
WO2020047408A1
(en)
|
2018-08-31 |
2020-03-05 |
Intra-Cellular Therapies, Inc. |
Novel methods
|